NO951432L - Farmasöytiske preparater - Google Patents

Farmasöytiske preparater

Info

Publication number
NO951432L
NO951432L NO951432A NO951432A NO951432L NO 951432 L NO951432 L NO 951432L NO 951432 A NO951432 A NO 951432A NO 951432 A NO951432 A NO 951432A NO 951432 L NO951432 L NO 951432L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
ranitidine
advantage
treatment
relates
Prior art date
Application number
NO951432A
Other languages
English (en)
Norwegian (no)
Other versions
NO951432D0 (no
Inventor
Alan Bye
Jill Evans
Paul Derrick Huckle
Laurence Francis Lacey
Peter John Rue
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO951432D0 publication Critical patent/NO951432D0/no
Publication of NO951432L publication Critical patent/NO951432L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO951432A 1992-10-13 1995-04-12 Farmasöytiske preparater NO951432L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929221414A GB9221414D0 (en) 1992-10-13 1992-10-13 Pharmaceutical compositions
PCT/EP1993/002763 WO1994008560A1 (en) 1992-10-13 1993-10-11 Ranitidine chewable tablets

Publications (2)

Publication Number Publication Date
NO951432D0 NO951432D0 (no) 1995-04-12
NO951432L true NO951432L (no) 1995-05-12

Family

ID=10723323

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951432A NO951432L (no) 1992-10-13 1995-04-12 Farmasöytiske preparater

Country Status (25)

Country Link
US (1) US5593685A (cs)
EP (2) EP0664697B1 (cs)
JP (1) JP2918691B2 (cs)
KR (1) KR950703327A (cs)
AT (1) ATE166572T1 (cs)
AU (1) AU676690B2 (cs)
BG (1) BG99567A (cs)
CA (1) CA2147000A1 (cs)
CZ (1) CZ94495A3 (cs)
DE (1) DE69318844T2 (cs)
ES (1) ES2117718T3 (cs)
GB (1) GB9221414D0 (cs)
HU (2) HUT72497A (cs)
IL (1) IL107255A (cs)
MX (1) MX9306333A (cs)
NO (1) NO951432L (cs)
NZ (1) NZ256681A (cs)
OA (1) OA10144A (cs)
PH (1) PH31433A (cs)
PL (1) PL174359B1 (cs)
SG (1) SG49850A1 (cs)
SK (1) SK48395A3 (cs)
TW (1) TW271405B (cs)
WO (1) WO1994008560A1 (cs)
ZA (1) ZA937544B (cs)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
GB9418530D0 (en) * 1994-09-14 1994-11-02 Glaxo Group Ltd Medicaments
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
AU7468096A (en) * 1995-10-30 1997-05-22 Warner-Lambert Company Enhanced anti-inflammatory oral composition containing h2 receptor antagonist and antimicrobial oils
DE19639343C2 (de) * 1996-09-25 1998-10-08 Suedzucker Ag Komprimate, enthaltend ein Süßungsmittelgemisch
GB9715423D0 (en) 1997-07-23 1997-09-24 Glaxo Group Ltd Aqueous compositions
US6086920A (en) * 1998-08-12 2000-07-11 Fuisz Technologies Ltd. Disintegratable microspheres
US6627234B1 (en) 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
US6531114B1 (en) 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
US7163705B2 (en) * 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
US6586023B1 (en) 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
US20020159956A1 (en) * 1999-04-06 2002-10-31 Ream Ronald L. Over-coated chewing gum formulations
US7935362B2 (en) * 1999-04-06 2011-05-03 Wm. Wrigley Jr. Company Over-coated product including consumable center and medicament
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6426090B1 (en) * 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US6569472B1 (en) 2000-09-01 2003-05-27 Wm. Wrigley Jr. Company Coated chewing gum products containing antacid and method of making
US6645535B2 (en) 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids
US6541048B2 (en) 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US6663849B1 (en) 2000-09-01 2003-12-16 Wm. Wrigley Jr. Company Antacid chewing gum products coated with high viscosity materials
US9253991B2 (en) 1999-09-20 2016-02-09 Jack Barreca Chewing gum with B vitamins
US6491540B1 (en) * 1999-09-20 2002-12-10 Jack Barreca Center-filled supplement gum
US9387168B2 (en) 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
US6572900B1 (en) 2000-06-09 2003-06-03 Wm. Wrigley, Jr. Company Method for making coated chewing gum products including a high-intensity sweetener
US7115288B2 (en) * 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
US6444241B1 (en) 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
US6579545B2 (en) 2000-12-22 2003-06-17 Wm. Wrigley Jr. Company Coated chewing gum products containing an antigas agent
JP5412966B2 (ja) * 2009-06-08 2014-02-12 ライオン株式会社 粒状製剤
CN109010303B (zh) * 2017-06-09 2021-05-07 苏州科伦药物研究有限公司 一种盐酸雷尼替丁胶囊的工业制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0349103B1 (en) * 1988-05-04 1992-11-25 Smith Kline & French Laboratories Limited Chewable tablet
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2052679C (en) * 1990-08-30 1997-12-02 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
DE69211688T2 (de) * 1991-04-04 1997-02-06 Procter & Gamble Kaubare antacida
BR9205827A (pt) * 1991-04-04 1994-06-28 Procter & Gamble Composições farmacêuticas ingeriveis para tratamento de distúrbios do trato gastrintestinal superior
DK0587744T3 (da) * 1991-05-28 2003-10-20 Mcneil Ppc Inc Tygbar sammensætning til frigørelse af et lægemiddel
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
CA2079934C (en) * 1991-10-15 2002-09-03 Edward J. Roche Taste mask coatings for preparing chewable pharmaceutical tablets
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Also Published As

Publication number Publication date
NO951432D0 (no) 1995-04-12
JP2918691B2 (ja) 1999-07-12
SK48395A3 (en) 1995-11-08
IL107255A0 (en) 1994-01-25
JPH08502272A (ja) 1996-03-12
US5593685A (en) 1997-01-14
MX9306333A (es) 1995-01-31
TW271405B (cs) 1996-03-01
SG49850A1 (en) 1998-06-15
EP0664697B1 (en) 1998-05-27
ES2117718T3 (es) 1998-08-16
BG99567A (en) 1995-12-29
EP0788789A1 (en) 1997-08-13
NZ256681A (en) 1997-10-24
ZA937544B (en) 1994-04-21
HUT72497A (en) 1996-05-28
PH31433A (en) 1998-11-03
AU676690B2 (en) 1997-03-20
GB9221414D0 (en) 1992-11-25
EP0664697A1 (en) 1995-08-02
WO1994008560A1 (en) 1994-04-28
DE69318844T2 (de) 1998-10-15
AU5143493A (en) 1994-05-09
HU211847A9 (en) 1995-12-28
HU9501053D0 (en) 1995-06-28
ATE166572T1 (de) 1998-06-15
DE69318844D1 (de) 1998-07-02
IL107255A (en) 1998-07-15
CZ94495A3 (en) 1995-10-18
CA2147000A1 (en) 1994-04-28
PL308356A1 (en) 1995-07-24
PL174359B1 (pl) 1998-07-31
OA10144A (en) 1996-12-18
KR950703327A (ko) 1995-09-20

Similar Documents

Publication Publication Date Title
NO951432D0 (no) Farmasöytiske preparater
DE122006000010I2 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3-Benzazepin-2-ones, verwendbar in derBehandlung von kardiovaskularen Krankheiten
NO1994018I1 (no) Mometasonfuroat
ATE210127T1 (de) 6-substituierte mycophenolsäurederivate mit immun suppressiver wirkung
DK465488A (da) Farmaceutisk praeparat indeholdende en triazol-forbindelse
NO923643L (no) Legemiddel for behandling av gastrointestinale forstyrrelser
DE69221617D1 (de) Aufbereitung von flüssigkeit
FI891986A (fi) Farmaceutiska sammansaettningar foer behandling av psoriasis.
NO934197L (no) Vitamin D-3-analoger
DE68911776T2 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
EP0378824A3 (en) Use of omega-3-fatty acids as anticachexia agents
DK561589A (da) Flydende oralt farmaceutisk praeparat
MX9203305A (es) Tratamiento de acidos organo sulfonicos.
DE3863093D1 (de) Sulfosuccinamidsaeuren von polyoxypropylendiaminen und ihre verwendung als emulgatoren.
DE3769332D1 (de) Derivate von pyrido-menadion-additionsprodukten und verwendungen davon.
DE3869914D1 (de) Proteinartige derivate mit gehalt an eisen in hoher bio-nutzbarer form, die zubereitung hiervon und die sie enthaltenden pharmazeutischen zusammensetzungen.
IT8421358A0 (it) Derivato della ranitidina utile nel trattamento dell'ulcera.
DE3869232D1 (de) Abkoemmlinge von bornan-3-spiro-l'-cyclopentan und diese enthaltende riechstoffzusammensetzungen.
NO912528D0 (no) Behandling av sykdommer forbundet med jodmangel.
ATE62678T1 (de) Derivate von pyrido-menadion-additionsprodukten und verwendungen davon.
ATE102478T1 (de) Kosmetische und hautbehandlungszusammensetzungen.
SU1732643A1 (ru) Амиды n-этоксиоксалилантраниловой кислоты, проявляющие противовоспалительную и анальгетическую активность